Cabio Biotech Stock Forecast - Simple Regression

688089 Stock   18.03  0.06  0.33%   
The Simple Regression forecasted value of Cabio Biotech Wuhan on the next trading day is expected to be 20.17 with a mean absolute deviation of 1.29 and the sum of the absolute errors of 78.47. Cabio Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cabio Biotech stock prices and determine the direction of Cabio Biotech Wuhan's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cabio Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Cabio Biotech's Accounts Payable is projected to increase significantly based on the last few years of reporting. The current year's Cash is expected to grow to about 458.3 M, whereas Total Assets are forecasted to decline to about 1.2 B.
Simple Regression model is a single variable regression model that attempts to put a straight line through Cabio Biotech price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Cabio Biotech Simple Regression Price Forecast For the 10th of January

Given 90 days horizon, the Simple Regression forecasted value of Cabio Biotech Wuhan on the next trading day is expected to be 20.17 with a mean absolute deviation of 1.29, mean absolute percentage error of 3.25, and the sum of the absolute errors of 78.47.
Please note that although there have been many attempts to predict Cabio Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cabio Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Cabio Biotech Stock Forecast Pattern

Backtest Cabio BiotechCabio Biotech Price PredictionBuy or Sell Advice 

Cabio Biotech Forecasted Value

In the context of forecasting Cabio Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cabio Biotech's downside and upside margins for the forecasting period are 15.97 and 24.36, respectively. We have considered Cabio Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
18.03
20.17
Expected Value
24.36
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Cabio Biotech stock data series using in forecasting. Note that when a statistical model is used to represent Cabio Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria119.2889
BiasArithmetic mean of the errors None
MADMean absolute deviation1.2864
MAPEMean absolute percentage error0.0618
SAESum of the absolute errors78.469
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Cabio Biotech Wuhan historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Cabio Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cabio Biotech Wuhan. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
13.8518.0422.23
Details
Intrinsic
Valuation
LowRealHigh
12.6816.8721.06
Details
Bollinger
Band Projection (param)
LowMiddleHigh
16.7419.7422.73
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cabio Biotech. Your research has to be compared to or analyzed against Cabio Biotech's peers to derive any actionable benefits. When done correctly, Cabio Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cabio Biotech Wuhan.

Other Forecasting Options for Cabio Biotech

For every potential investor in Cabio, whether a beginner or expert, Cabio Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cabio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cabio. Basic forecasting techniques help filter out the noise by identifying Cabio Biotech's price trends.

Cabio Biotech Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cabio Biotech stock to make a market-neutral strategy. Peer analysis of Cabio Biotech could also be used in its relative valuation, which is a method of valuing Cabio Biotech by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Cabio Biotech Wuhan Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cabio Biotech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cabio Biotech's current price.

Cabio Biotech Market Strength Events

Market strength indicators help investors to evaluate how Cabio Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cabio Biotech shares will generate the highest return on investment. By undertsting and applying Cabio Biotech stock market strength indicators, traders can identify Cabio Biotech Wuhan entry and exit signals to maximize returns.

Cabio Biotech Risk Indicators

The analysis of Cabio Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cabio Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cabio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Other Information on Investing in Cabio Stock

Cabio Biotech financial ratios help investors to determine whether Cabio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cabio with respect to the benefits of owning Cabio Biotech security.